April 28, 2025 07:03 AM EDT
Pharma
FDA+

Eu­ro­pean reg­u­la­tors rec­om­mend new drugs from Ver­tex, Am­gen and Jazz 

Anna Brown

News Reporter

Ver­tex Phar­ma­ceu­ti­cals, Am­gen and Jazz Phar­ma­ceu­ti­cals are among com­pa­nies that re­ceived a pos­i­tive opin­ion from Eu­ro­pean reg­u­la­tors for drugs that are al­ready in the US …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Rev­o­lu­tion Med­i­ci­nes' KRAS drug shows po­ten­tial in ear­ly cut of lung can­cer da­ta

Ex­clu­sive: Can AI re­place an­i­mal test­ing? A new biotech launch­es to find out

France stops Val­neva's chikun­gun­ya vac­cine roll­out in over 65s af­ter safe­ty is­sue

GSK’s check­point block­er Jem­per­li cures bio­mark­er-dri­ven rec­tal can­cer

Keytru­da around head and neck can­cer surgery cuts chance of dis­ease com­ing back

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times